Soumyadeep Bhaumik
Appearance
Soumyadeep Bhaumik | |
---|---|
Nationality | Indian |
Citizenship | Indian |
Education | MBBS, M.Sc, PhD (Medicine) |
Alma mater | Bankura Sammilani Medical College
Liverpool School of Tropical Medicine University of New South Wales |
Known for | Advocacy leading to change in National COVID-19 treatment guidelines in India; and setting up first Rapid Evidence Synthesis Unit in India |
Scientific career | |
Fields | Evidence Synthesis, Health Policy, Snakebite |
Institutions | George Institute for Global Health |
Thesis | Addressing the burden of snakebite: analysing policy prioritisation, evaluating health systems, and fostering research on treatments |
Website | www.soumyadeepbhaumik.in |
Soumyadeep Bhaumik is an Indian medical doctor and public health researcher who heads the Meta-research and Evidence Synthesis Unit in George Institute for Global Health.[1] In 2021, Bhaumik and other scientists advocated for the removal of convalescent plasma from COVID-19 treatment guidelines through an open letter to the Principal Scientific Advisor, Government of India.[2][3] He is among top 2% of most cited researchers globally in field of general and internal medicine.[4][5] Bhaumik is also Associate Editor, BMJ Global Health[6]
References
- ^ "George Institute for Global Health".
- ^ "Scientists raise concern over 'non-scientific use of convalescent plasma for Covid patients' in India". The Indian Express. 2021-05-11. Retrieved 2023-10-18.
- ^ "COVID: Public Health Experts Pen Concerns About Plasma to PSA VijayRaghavan". The Wire. Retrieved 2023-10-18.
- ^ Ioannidis, John P. A.; Boyack, Kevin W.; Baas, Jeroen (2020-10-16). "Updated science-wide author databases of standardized citation indicators". PLOS Biology. 18 (10): e3000918. doi:10.1371/journal.pbio.3000918. ISSN 1545-7885. PMC 7567353. PMID 33064726.
- ^ "George Institute researchers having global impact".
- ^ "Editorial Board BMJ Global Health".